ATE378364T1 - Polyamhydride mit therapeutisch verwendbaren abbauprodukten - Google Patents

Polyamhydride mit therapeutisch verwendbaren abbauprodukten

Info

Publication number
ATE378364T1
ATE378364T1 AT98946004T AT98946004T ATE378364T1 AT E378364 T1 ATE378364 T1 AT E378364T1 AT 98946004 T AT98946004 T AT 98946004T AT 98946004 T AT98946004 T AT 98946004T AT E378364 T1 ATE378364 T1 AT E378364T1
Authority
AT
Austria
Prior art keywords
ortho
aromatic
substituted
dicarboxylic acid
well
Prior art date
Application number
AT98946004T
Other languages
English (en)
Inventor
Kathryn Uhrich
Original Assignee
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rutgers filed Critical Univ Rutgers
Application granted granted Critical
Publication of ATE378364T1 publication Critical patent/ATE378364T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G67/00Macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing oxygen or oxygen and carbon, not provided for in groups C08G2/00 - C08G65/00
    • C08G67/04Polyanhydrides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Polyethers (AREA)
AT98946004T 1997-09-10 1998-09-10 Polyamhydride mit therapeutisch verwendbaren abbauprodukten ATE378364T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5832897P 1997-09-10 1997-09-10

Publications (1)

Publication Number Publication Date
ATE378364T1 true ATE378364T1 (de) 2007-11-15

Family

ID=22016145

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98946004T ATE378364T1 (de) 1997-09-10 1998-09-10 Polyamhydride mit therapeutisch verwendbaren abbauprodukten

Country Status (13)

Country Link
EP (1) EP1032605B1 (de)
JP (2) JP4130305B2 (de)
KR (1) KR20010023852A (de)
CN (1) CN1158325C (de)
AT (1) ATE378364T1 (de)
AU (1) AU750424C (de)
CA (1) CA2302508C (de)
CY (1) CY1107857T1 (de)
DE (1) DE69838731T2 (de)
DK (1) DK1032605T3 (de)
ES (1) ES2296344T3 (de)
PT (1) PT1032605E (de)
WO (1) WO1999012990A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6468519B1 (en) * 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
US7985415B2 (en) 1997-09-10 2011-07-26 Rutgers, The State University Of New Jersey Medical devices employing novel polymers
US7122615B1 (en) 1998-09-10 2006-10-17 Rutgers, The State University Of New Jersey Polyanhydrides with therapeutically useful degradation products
US6486214B1 (en) * 1997-09-10 2002-11-26 Rutgers, The State University Of New Jersey Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
US6685928B2 (en) * 1999-12-07 2004-02-03 Rutgers, The State University Of New Jersey Therapeutic compositions and methods
ATE444086T1 (de) 1999-12-07 2009-10-15 Univ Rutgers Therapeutische zusammensetzungen und verfahren zur behandlung von periodontitis mit entzündunshemmenden mitteln
US20040038948A1 (en) 1999-12-07 2004-02-26 Uhrich Kathryn E. Therapeutic compositions and methods
US7875283B2 (en) 2000-04-13 2011-01-25 Advanced Cardiovascular Systems, Inc. Biodegradable polymers for use with implantable medical devices
US8109994B2 (en) 2003-01-10 2012-02-07 Abbott Cardiovascular Systems, Inc. Biodegradable drug delivery material for stent
WO2002009769A2 (en) 2000-07-27 2002-02-07 Rutgers, The State University Of New Jersey Therapeutic azo-compounds for drug delivery
CA2771263A1 (en) 2000-07-27 2002-02-07 Rutgers, The State University Therapeutic polyesters and polyamides
IL140017A (en) * 2000-11-30 2009-09-22 Abraham J Domb Polyhedra
AU2002357762A1 (en) 2001-11-23 2003-06-10 Theodore James Anastasion Improved synthesis of polyanhyrides
JP2005520640A (ja) * 2002-03-20 2005-07-14 アドヴァンスド カーディオヴァスキュラー システムズ, インコーポレイテッド ステント用の生物分解性疎水性ポリマー
US20070098800A1 (en) * 2002-10-28 2007-05-03 Giroux Karen J Therapeutic compositions
AU2003295635A1 (en) * 2002-11-18 2004-06-15 Polymerix Corporation Medical devices employing novel polymers
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
EP1744787A4 (de) * 2004-05-14 2011-04-06 Interface Biologics Inc Polymer-kupplungsmittel und daraus hergestellte pharmazeutisch wirksame polymere
US8143368B2 (en) 2004-12-23 2012-03-27 Massachusetts Institute Of Technology Disposable medical supplies from hydrolytically biodegradable plastics
US8263060B2 (en) 2005-05-23 2012-09-11 Rutgers, The State University Of New Jersey Fast degrading polymers
EP1951260A4 (de) 2005-10-21 2009-11-11 Bezwada Biomedical Llc Funktionalisierte phenolische verbindungen und saugfähiger artikel daraus
US8007526B2 (en) 2005-12-01 2011-08-30 Bezwada Biomedical, Llc Difunctionalized aromatic compounds and polymers therefrom
JP2009539501A (ja) * 2006-06-06 2009-11-19 ラトガーズ, ザ ステイト ユニバーシティ オブ ニュー ジャージー ヨウ化ポリマー
EP2102144A4 (de) 2006-09-13 2011-03-23 Univ Rutgers Wirkstoffe und ihre oligomere und polymere
EP2146701B1 (de) 2007-04-12 2013-10-16 Rutgers, The State University of New Jersey Biologisch abbaubare polyanhydride mit natürlichen bioaktiven molekülen
US8217134B2 (en) 2007-08-30 2012-07-10 Bezwada Biomedical, Llc Controlled release of biologically active compounds
US8048980B2 (en) 2007-09-17 2011-11-01 Bezwada Biomedical, Llc Hydrolysable linkers and cross-linkers for absorbable polymers
CN101357244B (zh) * 2008-09-18 2011-06-01 复旦大学附属肿瘤医院 纳米粒子增强的光固化聚酸酐载药聚合物支架的制备方法
EP2569015A1 (de) 2010-05-14 2013-03-20 Iberhospitex S.A. Verbindungen zur synthese von biostabilen polyurethan-, polyharnstoff- oder polyharnstoffurethanpolymeren
US20140030341A1 (en) * 2011-04-06 2014-01-30 Rutgers, The State University Of New Jersey Polymers and methods for the treatment of pain
AU2013232297B2 (en) * 2012-03-16 2016-01-14 The Johns Hopkins University Controlled release formulations for the delivery of HIF-1 inhibitors
EP2825207B1 (de) * 2012-03-16 2020-08-19 The Johns Hopkins University Nichtlineare multiblock-copolymer-arzneimittelkonjugate zur verabreichung von wirkstoffen
US9144579B2 (en) 2012-08-17 2015-09-29 Rutgers, The State University Of New Jersey Polyesters and methods of use thereof
US20140120057A1 (en) 2012-10-25 2014-05-01 Rutgers, The State University Of New Jersey Polymers and methods thereof for wound healing
CN103910875B (zh) * 2012-12-31 2017-06-13 张雅珍 蒽环类抗生素偶联非线性多嵌段共聚物及其制备方法和应用
US9387250B2 (en) 2013-03-15 2016-07-12 Rutgers, The State University Of New Jersey Therapeutic compositions for bone repair
WO2014194055A1 (en) 2013-05-29 2014-12-04 Rutgers, The State University Of New Jersey Antioxidant-based poly(anhydride-esters)
US10023521B2 (en) 2014-06-13 2018-07-17 Rutgers, The State University Of New Jersey Process and intermediates for preparing poly(anhydride-esters)
WO2016097848A1 (en) 2014-12-18 2016-06-23 Dexcel Pharma Technologies Ltd. Alternating and semi-alternating poly(ester-anhydride) copolymers
WO2016164898A1 (en) 2015-04-10 2016-10-13 Rutgers, The State University Of New Jersey Kojic acid polymers
EP3600438A4 (de) 2017-03-29 2020-10-28 Dexcel Pharma Technologies Ltd. Zusammensetzungen mit biologisch abbaubaren copolymeren
WO2019148294A1 (en) 2018-02-02 2019-08-08 Interface Biologics, Inc. Dimeric dexamethasone prodrug compositions and uses thereof
US12473326B2 (en) 2019-02-01 2025-11-18 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
CN114126598B (zh) * 2019-07-05 2024-05-31 密歇根大学董事会 用于嗜中性粒细胞损伤的聚合物颗粒
US20220347305A1 (en) 2019-08-07 2022-11-03 Ripple Therapeutics Corporation Controlled release drug dimers
WO2021220061A2 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2607799A (en) * 1949-09-22 1952-08-19 Monsanto Chemicals Process for the preparation of glycol esters of benzyl acid phthalate
JPS51134729A (en) * 1975-05-20 1976-11-22 Asahi Chem Ind Co Ltd Powdered coating composition
JPS5382743A (en) * 1976-12-27 1978-07-21 Okura Ind Co Ltd Preparation of glycol trimellitic acid anhydrides
JPS567716A (en) * 1979-07-03 1981-01-27 Chugai Pharmaceut Co Ltd Preventive and remedy for cerebral angiospasm
US4757128A (en) * 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
US4886870A (en) * 1984-05-21 1989-12-12 Massachusetts Institute Of Technology Bioerodible articles useful as implants and prostheses having predictable degradation rates
US4891225A (en) * 1984-05-21 1990-01-02 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
JPS6119649A (ja) * 1984-07-06 1986-01-28 Adeka Argus Chem Co Ltd ポリ塩化ビニル系樹脂組成物
CH671402A5 (de) * 1985-10-02 1989-08-31 Sandoz Ag
DE3670206D1 (de) * 1986-05-20 1990-05-17 Massachusetts Inst Technology Bioerodierbare erzeugnisse zur verwendung als implantate oder prothese mit einem voraussehbaren resorbierungsgrad.
US4997904A (en) * 1989-08-25 1991-03-05 Nova Pharmaceutical Corporation Aromatic polyanhydride compositions
DD288387A5 (de) * 1989-10-16 1991-03-28 Friedrich-Schiller-Universitaet Jena,De Verfahren zur herstellung von poly(esteranhydriden)
DD288311A5 (de) * 1989-10-16 1991-03-28 Friedrich-Schiller-Universitaet Jena,De Verfahren zur gesteuerten freisetzung von biologisch aktiven verbindungen
CA2072360A1 (en) * 1989-12-26 1991-06-27 Abraham J. Domb Prodrug anhydride compositions
US5175235A (en) * 1990-06-04 1992-12-29 Nova Pharmaceutical Corporation Branched polyanhydrides
US5264540A (en) * 1992-07-20 1993-11-23 Ethicon, Inc. Aromatic polyanhydrides
JPH06172426A (ja) * 1992-12-08 1994-06-21 Shin Etsu Chem Co Ltd 側鎖にアセチルサリチル酸基を有する重合体
US5364725A (en) * 1993-03-15 1994-11-15 Eastman Kodak Company Toner and developer containing acyloxy-t-alkylated benzoic acids as charge-control agent
JP3255197B2 (ja) * 1993-05-26 2002-02-12 株式会社リコー 感熱記録材料
JP3091366B2 (ja) * 1993-06-25 2000-09-25 信越化学工業株式会社 アセチルサリチル酸ビニル−ビニルアルコール系共重合体
JP3122977B2 (ja) * 1993-12-01 2001-01-09 富士写真フイルム株式会社 感熱記録材料
US5637113A (en) * 1994-12-13 1997-06-10 Advanced Cardiovascular Systems, Inc. Polymer film for wrapping a stent structure
US6060212A (en) * 1998-06-11 2000-05-09 Clariant Finance (Bvi) Limited 193 nm positive-working photoresist composition
ATE444086T1 (de) * 1999-12-07 2009-10-15 Univ Rutgers Therapeutische zusammensetzungen und verfahren zur behandlung von periodontitis mit entzündunshemmenden mitteln
US6685928B2 (en) * 1999-12-07 2004-02-03 Rutgers, The State University Of New Jersey Therapeutic compositions and methods
CN1520297A (zh) * 2001-04-26 2004-08-11 ���ߵ���Ƶϵͳ��˾ 包含复合药物(codrugs)的缓释药物传递系统
AU2002357762A1 (en) * 2001-11-23 2003-06-10 Theodore James Anastasion Improved synthesis of polyanhyrides

Also Published As

Publication number Publication date
PT1032605E (pt) 2007-12-12
AU750424B2 (en) 2002-07-18
CY1107857T1 (el) 2013-06-19
WO1999012990A1 (en) 1999-03-18
DE69838731T2 (de) 2008-04-10
DE69838731D1 (de) 2007-12-27
JP2008150367A (ja) 2008-07-03
CN1158325C (zh) 2004-07-21
ES2296344T3 (es) 2008-04-16
CN1269811A (zh) 2000-10-11
AU750424C (en) 2003-05-15
AU9311798A (en) 1999-03-29
DK1032605T3 (da) 2008-03-17
CA2302508A1 (en) 1999-03-18
EP1032605B1 (de) 2007-11-14
KR20010023852A (ko) 2001-03-26
JP2001515934A (ja) 2001-09-25
EP1032605A1 (de) 2000-09-06
EP1032605A4 (de) 2002-03-13
JP4130305B2 (ja) 2008-08-06
CA2302508C (en) 2011-03-15

Similar Documents

Publication Publication Date Title
EP1032605A4 (de) Polyamhydride mit therapeutisch verwendbaren abbauprodukten
TR199800258T1 (xx) Yeni opioid peptidler.
DK1020179T3 (da) Peptidderivater eller farmaceutisk acceptable salte deraf, fremgangsmåde til fremstilling af de samme, anvendelse af derivaterne og farmaceutisk sammensætning
DE60036306D1 (de) System zur verabreichung von medikamenten mit veränderbarer rate
DK0617623T3 (da) Acetylsalicylsyreholdigt transdermalt indgivelsessystem til antithrombotisk behandling
EP2218734A3 (de) Analoge des Glucagon ähnlichen Peptides-2
DE69805001D1 (de) Osmotische darreichungsform mit zwei mantelschichten
DK0998287T3 (da) Anvendelse af levobupivacain
DE69900207D1 (de) Verwendung von 11-(3-dimethylaminopropyliden)-6,11-dihydrodibenz[b,e]oxepin-2-essigsäure und deren pharmazeutisch annehmbaren salzen zur herstellung eines medikaments zur behandlung nicht-allergisch-bedingten augenentzündungen und zur prevention der okularen neovaskularisation
EA199900734A1 (ru) Микрокапсулы, содержащие цис-платину
WO2000021548A3 (en) Angiogenically effective unit dose of fgf and method of administering
NO172028C (no) Fremgangsmaate for fremstilling av transdermalt resorberbare preparater av arylpropionsyrer
IS4923A (is) Meðferðaráform við inngjöf á H+,K+-ATPasa-blokkara
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
DK1039900T3 (da) Farmaceutisk præparat indeholdende sibutramin og orlistat
ATE94401T1 (de) Physiologisch wirkende substanzen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen davon.
AU3401093A (en) Therapeutic agent for threatened abortion
EE9700231A (et) Aminotetraliini derivaat kardiovaskulaarsete haiguste raviks
ATE122561T1 (de) Pharmazeutische zubereitung mit wirkung auf das herzgefässsystem, die 3-methylthiopropionyl l- carnitin enthält.
ITTO930661A0 (it) Derivati acidi poliamidici ad attivita' antigastrinica, procedimento per la loro preparazione e loro uso farmaceutico.
CA2290739A1 (en) New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy
DK0667151T3 (da) Oralt lægemiddelpræparat indeholdende diclofenacnatrium og en organisk syre
DE69412612D1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
IT8721540A0 (it) Composizioni farmaceutiche contenenti trapidil, loro procedimento di preparazione erelativo impiego terapeutico.
ES2105815T3 (es) Nuevos derivados de hidrazino- e hidroxiamino-14beta-hidroxiandrostano activos sobre el sistema cardiovascular, procesos para su preparacion y composiciones farmaceuticas que contienen los mismos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1032605

Country of ref document: EP